Glenwood Village Care Center: Antibiotic Oversight Failures - MN
The case manager who spoke with inspectors first, identified in the report as CM-A, confirmed there had been no reevaluation of how long the antibiotic should continue or why. The resident's primary care provider hadn't yet weighed in. The plan, as of that afternoon, was to ask the provider to add supporting documentation the following day, during scheduled rounds.
A second case manager, CM-B, said she wasn't aware the resident was receiving the antibiotic at all. She thought it had probably been ordered because another medication had been stopped. She said she would review the resident's electronic medication record and provide documentation if she found any.
The director of nursing said she was also unaware the resident was taking it.
The facility's medical director, reached by phone the following morning, said he was not the resident's primary provider and had no knowledge of the prophylaxis antibiotic. He said he was aware the resident had a history of frequent urinary tract infections and guessed the medication was probably related to that history. He said he would speak with the provider and make sure a rationale and duration were documented.
Nobody had done that before inspectors arrived.
The consultant pharmacist, who spoke with inspectors by phone that afternoon, offered the clearest picture of what had gone wrong. The facility had cycled through more than one consultant pharmacist over the previous six months, and notes about the resident's antibiotic had been entered into the pharmacy's system but not into the facility's own records. The pharmacist said the physician needed additional notes and justification to support continued use of the drug, and stated plainly that the facility should have reevaluated whether the antibiotic was still appropriate.
That reevaluation never happened. There is no indication in the inspection report that anyone at the facility had formally reviewed the medication's continued use, documented a clinical basis for keeping the resident on it, or flagged it through any internal oversight process.
The facility's own antibiotic stewardship policy, revised as recently as February 2025, described a system in which antibiotics would be prescribed for the correct indication, dose, and duration, and in which prescribing practitioners would receive periodic reviews of their antibiotic use. The policy called for feedback to practitioners on prescribing patterns and antibiotic resistance. It described a monitoring system designed to catch exactly this kind of situation.
The monitoring system did not catch it.
Inspectors reviewed the facility's quality assurance and performance improvement meeting minutes spanning February through May of 2025. The active projects documented in those minutes included hand hygiene, protective equipment use, falls, and barrier precautions. The antibiotic stewardship program did not appear in any of them.
The director of nursing, who also served as the facility's infection preventionist, told inspectors she expected all medications to have proper diagnoses, durations, and rationales documented when residents were receiving antibiotics. She said antibiotic use would have been discussed at those quality meetings.
It was not discussed. Not once, across four months of meeting minutes.
What makes the lapse harder to dismiss is the resident's medical profile. A history of recurring sepsis tied to urinary tract infections, combined with a urostomy and a history of bladder cancer, makes antibiotic stewardship more consequential, not less. Long-term prophylactic antibiotic use without documented clinical justification or periodic review carries real risks, including the development of antibiotic-resistant organisms, which the facility's own policy identified as a concern. For a resident already cycling through serious infections, the margin for error is narrow.
The inspection report cited the deficiency under F0881, the federal tag covering antibiotic stewardship programs, at a level of minimal harm or potential for actual harm, with many residents affected. That last designation reflects not just one resident's situation but a broader failure: a stewardship program that existed on paper, appeared in policy documents, and was assigned to staff by title, but had produced no documented oversight of antibiotic use in the months inspectors reviewed.
The medical director said he would talk to the provider. The case manager said she would look for documentation. The facility said it would ask for a rationale the next day, during rounds.
The resident had already been taking the antibiotic. For how long, and on what original basis, the inspection report does not say. No one interviewed by inspectors could say either.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Glenwood Village Care Center from 2025-05-21 including all violations, facility responses, and corrective action plans.
Additional Resources
Data source: Official federal inspection data from the Centers for Medicare & Medicaid Services (CMS).
Editorial process: AI-synthesized regulatory data, reviewed for accuracy by our editorial team.
Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.
Last verified: July 5, 2026 · Our methodology
GLENWOOD VILLAGE CARE CENTER in GLENWOOD, MN was cited for violations during a health inspection on May 21, 2025.
The resident's primary care provider hadn't yet weighed in.
Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.